FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2146524976> ?p ?o ?g. }

• W2146524976 endingPage "246" @default.
• W2146524976 startingPage "237" @default.
• W2146524976 abstract "PURPOSE: To improve efficacy and reduce toxic- ity of treatment for children with acute lymphoblas- tic leukemia. PATIENTS AND METHODS: Patients from all risk groups, including infants and those with T-cell disease, were treated between 1987 and 1991. Standard-risk (SR) patients did not receive cranial irradiation, whereas high-risk (HR) and very high-risk (VHR) patients participated in a randomized comparison of 18 Gy of cranial irradiation conventionally fractionated versus two fractions per day (hyperfractionated). RESULTS: At a median follow-up of 9.2 years, the 9-year event-free survival (EFS ± SE) was 75% ± 2% for all 369 patients, 77% ± 4% for the 142 SR patients, and 73% ± 3% for the 227 HR/VHR patients (P = .37 comparing SR and HR/VHR). The CNS, with or without concomitant bone marrow involvement, was the first site of relapse in 19 (13%) of the 142 SR patients: 16 (20%) of 79 SR boys and three (5%) of 63 SR girls. This high incidence of relapses necessitated a recall of SR boys for additional therapy. CNS relapse occurred in only two (1%) of 227 HR and VHR patients. There were no outcome differences found among randomized treatment groups. Nine-year overall survival was 84% ± 2% for the entire population, 93% ± 2% for SR children, and 79% ± 3% for HR and VHR children (P < .01 comparing SR and HR/VHR). CONCLUSION: A high overall survival outcome was obtained for SR patients despite the high risk of CNS relapse for SR boys, which was presumed to be associated with eliminating cranial radiation without intensifying systemic or intrathecal chemotherapy. For HR/VHR patients, inability to salvage after relapse (nearly all of which were in the bone marrow) remains a significant clinical problem." @default.
• W2146524976 created "2016-06-24" @default.
• W2146524976 creator A5005627687 @default.
• W2146524976 creator A5007271347 @default.
• W2146524976 creator A5023365950 @default.
• W2146524976 creator A5023366565 @default.
• W2146524976 creator A5040290360 @default.
• W2146524976 creator A5044759942 @default.
• W2146524976 creator A5048748466 @default.
• W2146524976 creator A5065937853 @default.
• W2146524976 creator A5071056027 @default.
• W2146524976 creator A5072375420 @default.
• W2146524976 creator A5081765963 @default.
• W2146524976 creator A5082614208 @default.
• W2146524976 creator A5082899595 @default.
• W2146524976 creator A5084991338 @default.
• W2146524976 creator A5089646214 @default.
• W2146524976 creator A5091343019 @default.
• W2146524976 date "2002-01-01" @default.
• W2146524976 modified "2023-10-17" @default.
• W2146524976 title "Treatment of Childhood Acute Lymphoblastic Leukemia: Results of Dana-Farber ALL Consortium Protocol 87-01" @default.
• W2146524976 cites W120469029 @default.
• W2146524976 cites W155388932 @default.
• W2146524976 cites W1854117681 @default.
• W2146524976 cites W1872798817 @default.
• W2146524976 cites W1916063969 @default.
• W2146524976 cites W1921877523 @default.
• W2146524976 cites W1939497674 @default.
• W2146524976 cites W1940732706 @default.
• W2146524976 cites W1949439387 @default.
• W2146524976 cites W1979300931 @default.
• W2146524976 cites W2004153775 @default.
• W2146524976 cites W2007208181 @default.
• W2146524976 cites W2025860464 @default.
• W2146524976 cites W2039677781 @default.
• W2146524976 cites W2040801831 @default.
• W2146524976 cites W2044934343 @default.
• W2146524976 cites W2048006890 @default.
• W2146524976 cites W2073140442 @default.
• W2146524976 cites W2087111337 @default.
• W2146524976 cites W2127153931 @default.
• W2146524976 cites W2139984188 @default.
• W2146524976 cites W2170012309 @default.
• W2146524976 cites W2317885747 @default.
• W2146524976 cites W2335926318 @default.
• W2146524976 cites W2336096370 @default.
• W2146524976 cites W2406100591 @default.
• W2146524976 cites W2796700885 @default.
• W2146524976 cites W3104963505 @default.
• W2146524976 cites W59733412 @default.
• W2146524976 cites W2995133996 @default.
• W2146524976 doi "https://doi.org/10.1200/jco.20.1.237" @default.
• W2146524976 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11773175" @default.
• W2146524976 hasPublicationYear "2002" @default.
• W2146524976 type Work @default.
• W2146524976 sameAs 2146524976 @default.
• W2146524976 citedByCount "40" @default.
• W2146524976 countsByYear W21465249762012 @default.
• W2146524976 countsByYear W21465249762013 @default.
• W2146524976 countsByYear W21465249762014 @default.
• W2146524976 countsByYear W21465249762015 @default.
• W2146524976 countsByYear W21465249762016 @default.
• W2146524976 countsByYear W21465249762017 @default.
• W2146524976 countsByYear W21465249762018 @default.
• W2146524976 countsByYear W21465249762020 @default.
• W2146524976 countsByYear W21465249762022 @default.
• W2146524976 crossrefType "journal-article" @default.
• W2146524976 hasAuthorship W2146524976A5005627687 @default.
• W2146524976 hasAuthorship W2146524976A5007271347 @default.
• W2146524976 hasAuthorship W2146524976A5023365950 @default.
• W2146524976 hasAuthorship W2146524976A5023366565 @default.
• W2146524976 hasAuthorship W2146524976A5040290360 @default.
• W2146524976 hasAuthorship W2146524976A5044759942 @default.
• W2146524976 hasAuthorship W2146524976A5048748466 @default.
• W2146524976 hasAuthorship W2146524976A5065937853 @default.
• W2146524976 hasAuthorship W2146524976A5071056027 @default.
• W2146524976 hasAuthorship W2146524976A5072375420 @default.
• W2146524976 hasAuthorship W2146524976A5081765963 @default.
• W2146524976 hasAuthorship W2146524976A5082614208 @default.
• W2146524976 hasAuthorship W2146524976A5082899595 @default.
• W2146524976 hasAuthorship W2146524976A5084991338 @default.
• W2146524976 hasAuthorship W2146524976A5089646214 @default.
• W2146524976 hasAuthorship W2146524976A5091343019 @default.
• W2146524976 hasConcept C120665830 @default.
• W2146524976 hasConcept C121332964 @default.
• W2146524976 hasConcept C126322002 @default.
• W2146524976 hasConcept C141071460 @default.
• W2146524976 hasConcept C168563851 @default.
• W2146524976 hasConcept C2779384505 @default.
• W2146524976 hasConcept C2908647359 @default.
• W2146524976 hasConcept C61511704 @default.
• W2146524976 hasConcept C71924100 @default.
• W2146524976 hasConcept C72563966 @default.
• W2146524976 hasConcept C88879693 @default.
• W2146524976 hasConcept C90924648 @default.
• W2146524976 hasConcept C99454951 @default.
• W2146524976 hasConceptScore W2146524976C120665830 @default.
• W2146524976 hasConceptScore W2146524976C121332964 @default.

• next